Connecticut Wealth Management LLC Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Connecticut Wealth Management LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 22.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,309 shares of the healthcare conglomerate’s stock after purchasing an additional 2,236 shares during the period. Connecticut Wealth Management LLC’s holdings in UnitedHealth Group were worth $6,480,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Bray Capital Advisors increased its holdings in UnitedHealth Group by 0.5% in the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after buying an additional 50 shares during the period. Raymond James & Associates raised its holdings in shares of UnitedHealth Group by 0.9% during the third quarter. Raymond James & Associates now owns 1,812,699 shares of the healthcare conglomerate’s stock worth $913,945,000 after purchasing an additional 16,850 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its position in UnitedHealth Group by 1.7% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 759,789 shares of the healthcare conglomerate’s stock worth $383,078,000 after purchasing an additional 12,732 shares during the period. James Hambro & Partners lifted its holdings in shares of UnitedHealth Group by 12.0% in the 3rd quarter. James Hambro & Partners now owns 182,903 shares of the healthcare conglomerate’s stock valued at $92,239,000 after buying an additional 19,564 shares during the period. Finally, Simon Quick Advisors LLC raised its position in UnitedHealth Group by 22.9% during the third quarter. Simon Quick Advisors LLC now owns 2,553 shares of the healthcare conglomerate’s stock valued at $1,287,000 after acquiring an additional 476 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Down 0.1 %

Shares of UnitedHealth Group stock traded down $0.52 during trading hours on Friday, reaching $492.45. 2,487,811 shares of the company were exchanged, compared to its average volume of 5,130,659. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The stock’s fifty day moving average is $482.32 and its 200 day moving average is $512.76. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The firm has a market cap of $453.09 billion, a PE ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $6.26 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Barclays raised their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Stephens reissued an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.